Publications
Download CSV
Download XLSX
Download TXT
Tables
2024 (855)
2023 (887)
2022 (831)
2021 (892)
2020 (640)
2019 (727)
2018 (651)
2017 (681)
2016 (664)
2015 (429)
2014 (376)
2013 (319)
2012 (245)
2011 (163)
2010 (139)
2000 (2)
1977 (2)
All (8503)
Infrastructure Units
Infrastructure Units list
Infrastructure Units table
Researchers
Subset
Documentation
About
Contact
Software
Login
Larhed M
JSON
CSV
XLSX
TXT
Family name
Larhed
Given name
Mats
Initials
M
ORCID
ORCID
0000-0001-6258-0635
Affiliations
Science for Life Laboratory, Department of Medicinal Chemistry Uppsala University SE-751 23 Uppsala SWEDEN.
3 publications
PubMed
DOI
Crossref
Inhibition of Insulin-Regulated Aminopeptidase by Imidazo [1,5-α]pyridines-Synthesis and Evaluation.
Engen K, Lundbäck T, Yadav A, ..., Hallberg M,
Larhed M
Int J Mol Sci
25
(5) - [2024-02-21; online 2024-02-21]
Chemical Biology Consortium Sweden (CBCS) [Collaborative]
PubMed
DOI
Crossref
Synthesis, Evaluation and Proposed Binding Pose of Substituted Spiro-Oxindole Dihydroquinazolinones as IRAP Inhibitors.
Engen K, Vanga SR,
Lundbäck T
, ...,
Larhed M
,
Rosenström U
ChemistryOpen
9
(3) 325-337 [2020-03-00; online 2020-03-02]
Chemical Biology Consortium Sweden (CBCS) [Collaborative]
PubMed
DOI
Crossref
A Series of Analogues to the AT 2R Prototype Antagonist C38 Allow Fine Tuning of the Previously Reported Antagonist Binding Mode.
Isaksson R
,
Lindman J
,
Wannberg J
, ...,
Gising J
,
Larhed M
ChemistryOpen
8
(1) 114-125 [2019-01-00; online 2019-01-24]
Drug Discovery and Development (DDD) [Collaborative]
SciLifeLab Data Centre
Publications
9.5.1